|
🐜
|
METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression
13 auth.
Peng Xia,
Hao Zhang,
Haofeng Lu,
Kequan Xu,
Xiang Jiang,
Yuke Jiang,
Xiangdong Gongye,
Zhang Chen,
Jie Liu,
Xi Chen,
...
Weijie Ma,
Zhongling Zhang,
Yufeng Yuan
|
5 |
2023 |
5
🐜
|
|
🐜
|
A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression
15 auth.
Kequan Xu,
Peng Xia,
Xiangdong Gongye,
Xiao Zhang,
Shuxian Ma,
Zhang Chen,
Hao Zhang,
Jie Liu,
Yingyi Liu,
Yonghua Guo,
...
Ye Yao,
Meng Gao,
Yiran Chen,
Zhonglin Zhang,
Yufeng Yuan
|
5 |
2022 |
5
🐜
|
|
🐬
|
ATIC inhibits autophagy in hepatocellular cancer through the AKT/FOXO3 pathway and serves as a prognostic signature for modeling patient survival
Hao Zhang,
Peng Xia,
Jie Liu,
Zhang Chen,
Weijie Ma,
Yufeng Yuan
|
5 |
2021 |
5
🐬
|
|
🐜
|
Multi-omics analysis revealed the role of extracellular vesicles in hepatobiliary & pancreatic tumor.
9 auth.
Xiangdong Gongye,
Ming‐Hung Tian,
Peng Xia,
Chengmin Qu,
Zhang Chen,
Jigang Wang,
...
Qian Zhu,
Zhijie Li,
Yufeng Yuan
|
2 |
2022 |
2
🐜
|
|
🐜
|
Research progress on immunotherapy targeting the tumor immune microenvironment for cholangiocarcinoma
8 auth.
Tianyin Ma,
Zhang Chen,
Yibo Chai,
Xiangdong Gongye,
Peng Xia,
Chenming Qu,
...
Ming‐Hung Tian,
Yufeng Yuan
|
0 |
2023 |
0
🐜
|
|
🐜
|
An Autophagy-Related Prognostic Signature and Verification that ATIC Inhibits Autophagy Through the AMPK/mTOR Pathway in Hepatocellular Carcinoma
7 auth.
Hao Zhang,
Peng Xia,
Jie Liu,
Xingxing Wang,
Zhang Chen,
Weijie Ma,
...
Yufeng Yuan
|
0 |
2021 |
0
🐜
|
|
🐜
|
Prognostic value of CSN5 in patients with digestive system cancers: a systematic review and meta-analysis
9 auth.
Yonghua Guo,
Meng Gao,
Ye Yao,
Jinghua Li,
Xi Chen,
Xingxing Wang,
...
Zhang Chen,
Yufeng Yuan,
Weijie Ma
|
0 |
2022 |
0
🐜
|
